ZNF236, zinc finger protein 236, 7776

N. diseases: 20; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes. 30137410 2019
CUI: C0014130
Disease: Endocrine System Diseases
Endocrine System Diseases
0.010 Biomarker group BEFREE These results illuminate the role of FANCA in GSIS and its protein interactions regulated by glucose stimulation that may explain the prevalence of β cell-specific endocrinopathies in FA patients. 31461451 2019
CUI: C0015625
Disease: Fanconi Anemia
Fanconi Anemia
0.010 Biomarker disease BEFREE These results illuminate the role of FANCA in GSIS and its protein interactions regulated by glucose stimulation that may explain the prevalence of β cell-specific endocrinopathies in FA patients. 31461451 2019
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
0.010 Biomarker disease BEFREE These results illuminate the role of FANCA in GSIS and its protein interactions regulated by glucose stimulation that may explain the prevalence of β cell-specific endocrinopathies in FA patients. 31461451 2019
CUI: C4529962
Disease: Fatty Liver Disease
Fatty Liver Disease
0.010 Biomarker disease BEFREE AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p. 31299062 2019
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.010 AlteredExpression phenotype BEFREE Maternal whole blood cell miRNA-340 is elevated in gestational diabetes and inversely regulated by glucose and insulin. 29358694 2018
CUI: C1962942
Disease: TRICHOMONAS VAGINALIS (finding)
TRICHOMONAS VAGINALIS (finding)
0.010 Biomarker disease BEFREE Trichomonas vaginalis cathepsin D-like aspartic proteinase (Tv-CatD) is positively regulated by glucose and degrades human hemoglobin. 29413946 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.010 AlteredExpression disease BEFREE The RUNX2 transcription factor mediates breast cancer (BC) metastasis to bone and is regulated by glucose availability. 25808624 2015
Secondary malignant neoplasm of bone
0.010 Biomarker disease BEFREE The RUNX2 transcription factor mediates breast cancer (BC) metastasis to bone and is regulated by glucose availability. 25808624 2015
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.010 AlteredExpression disease BEFREE The RUNX2 transcription factor mediates breast cancer (BC) metastasis to bone and is regulated by glucose availability. 25808624 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 AlteredExpression disease BEFREE Human gene datasets regulated by glucose were compared to gene datasets either dysregulated in HCC or regulated by other signaling pathways. 26380295 2015
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE In this study, we demonstrated that protein O-GlcNAcylation, a common post-translational modification of nucleocytoplasmic proteins with beta-N-acetyl-glucosamine and a process regulated by glucose metabolism, was markedly decreased in Alzheimer's disease cerebrum. 19451179 2009
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 Biomarker disease BEFREE In this study we employed the human neuroblastoma cell line SH-SY5Y, as an in vitro model for neuronal cells, to identify genes regulated by glucose deprivation. 17719568 2007
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.010 Biomarker disease BEFREE In this study we employed the human neuroblastoma cell line SH-SY5Y, as an in vitro model for neuronal cells, to identify genes regulated by glucose deprivation. 17719568 2007
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.010 Biomarker disease BEFREE In this study we employed the human neuroblastoma cell line SH-SY5Y, as an in vitro model for neuronal cells, to identify genes regulated by glucose deprivation. 17719568 2007
CUI: C0342335
Disease: insulin resistance in diabetes
insulin resistance in diabetes
0.010 AlteredExpression disease BEFREE Thus, TXNIP is a novel proapoptotic beta-cell gene elevated in insulin resistance/diabetes and up-regulated by glucose through a unique ChoRE and may link glucotoxicity and beta-cell apoptosis. 15705778 2005
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 Biomarker disease BEFREE We sequenced ZNF236 in patients with diabetic nephropathy and diabetes without nephropathy, as well as in unaffected controls. 12906866 2003
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 Biomarker group BEFREE We sequenced ZNF236 in patients with diabetic nephropathy and diabetes without nephropathy, as well as in unaffected controls. 12906866 2003
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 Biomarker disease BEFREE It seems improbable, therefore, that ZNF236 is a gene that confers DN susceptibility. 12906866 2003
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.010 Biomarker group BEFREE We sequenced ZNF236 in patients with diabetic nephropathy and diabetes without nephropathy, as well as in unaffected controls. 12906866 2003